ASBMR 2022 Rare Bone Disease Highlights: Episode 1

Episode 1 September 12, 2022 00:16:37
ASBMR 2022 Rare Bone Disease Highlights: Episode 1
COR2ED Medical Education
ASBMR 2022 Rare Bone Disease Highlights: Episode 1

Sep 12 2022 | 00:16:37

/

Show Notes

In this first episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Anna Teti (University of L’Aquila) to provide rare bone disease highlights from the Rare Diseases Symposium that preceded the ASBMR 2022 Annual Meeting.

Opening with an overview of ongoing clinical research in several rare bone diseases, Prof. Teti highlights the importance of preparing clinicians for unexpected adverse events. Notably, therapies used in the context of rare bone diseases can cause adverse events not seen if a common bone disease was treated. For osteogenesis imperfecta, she discusses a novel treatment based on umbilical cord mesenchymal stem cells. A safety study in 18 paediatric patients – three of whom received a pre-natal injection – is awaiting completion by the end of 2023. Initial safety data suggests that multiple stem cell transplantations in children with this disease is safe. Prof. Teti emphasizes the impact of achondroplasia, the most common rare bone disease, and one for which new treatments are also in development. Pharmacological treatment aims to reduce activity of the pathogenic, overactive variant of FGFR3 which causes the disease. She is confident that a treatment will be found that, at minimum, enhances quality of life in patients. Prof. Teti concludes with a review of the highly collaborative spirit of the Rare Diseases Symposium, emphasizing that patient well-being must be the driving force of research.

Other Episodes

Episode 1

July 16, 2021 00:12:16
Episode Cover

Hepatocellular carcinoma highlights from ASCO and WCGIC 2021

In this episode, Dr Choo discusses some key abstracts presented during the virtual ASCO and WCGIC congresses in 2021. Dr Choo comments that despite...

Listen

Episode 3

March 27, 2023 00:22:49
Episode Cover

Overview of efficacy and safety data of combination therapy with PARPi and NHAs

Overview of efficacy and safety data of combination therapy with PARPi and NHAs, incorporating the latest data presented and the impact for the treatment...

Listen

Episode

March 15, 2025 00:00:56
Episode Cover

Choose your podcast channel: oncology, obstetrics & gynecology, hematology and rare diseases

Here at COR2ED, we know your time is valuable.     To help you cut through the noise and go straight to relevant podcast episodes in...

Listen